ADVISORY, Aug. 24, 2012 (GLOBE NEWSWIRE) -- What: Durata Therapeutics, Inc. [DRTX], a pharmaceutical company focused on the development and commercialization of novel therapeutics for patients with infectious diseases and acute illnesses, will visit the NASDAQ MarketSite in Times Square.
